Notice of Proposed Sale · 144
Natera, Inc.
NTRANASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Natera, Inc.
- Issuer CIK
- 0001604821
- SEC file number
- 001-37478
- Phone
- 6509809190
- Person for whose account securities are to be sold
- JOHN FESKO
- Relationships to issuer
- OFFICER
- Street
- 13011 MCCALLEN PASS
- Street (continued)
- BLDG A, STE 100
- City
- AUSTIN
- State / country code
- TX
- Postal code
- 78753
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common Stock | 292 | 78,185.92 | 143,215,382 | 08/03/2026 | NASDAQ | ETrade Corporation |
Broker / market maker — proposed row 1, entry 1
- Name
- ETrade Corporation
- Street
- 3 Edison Financial
- City
- Alphareta
- State / country code
- GA
- Postal code
- 30005
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common Stock | 07/31/2026 | Restricted Stock Units | Issuer | 11,832 | N | 01/31/2025 | Services rendered |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| JOHN FESKO | COMMON STOCK | 07/28/2026 | 931 | 236,539.62 |
| JOHN FESKO | COMMON STOCK | 07/27/2026 | 782 | 203,703.79 |
| JOHN FESKO | COMMON STOCK | 05/26/2026 | 1,438 | 291,683.56 |
| JOHN FESKO | COMMON STOCK | 05/01/2026 | 291 | 59,992.56 |
Seller — prior-sale row 1, entry 1
- Name
- JOHN FESKO
- Street
- 13011 MCCALLEN PASS
- Street (continued)
- BLDG A, STE 100
- City
- AUSTIN
- State / country code
- TX
- Postal code
- 78753
Seller — prior-sale row 2, entry 1
- Name
- JOHN FESKO
- Street
- 13011 MCCALLEN PASS
- Street (continued)
- BLDG A, STE 100
- City
- AUSTIN
- State / country code
- TX
- Postal code
- 78753
Seller — prior-sale row 3, entry 1
- Name
- JOHN FESKO
- Street
- 13011 MCCALLEN PASS
- Street (continued)
- BLDG A, STE 100
- City
- AUSTIN
- State / country code
- TX
- Postal code
- 78753
Seller — prior-sale row 4, entry 1
- Name
- JOHN FESKO
- Street
- 13011 MCCALLEN PASS
- Street (continued)
- BLDG A, STE 100
- City
- AUSTIN
- State / country code
- TX
- Postal code
- 78753
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Remarks
The securities to be sold were acquired upon the vesting of restricted stock units during the period of July 31, 2026 through July 31, 2026.
Notice signature
- Notice date
- 08/03/2026
- Signed
- John Fesko
Company context
Natera™ is a global leader in cell-free DNA and precision medicine, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 400 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California, and through Foresight Diagnostics, its subsidiary, operates an ISO 27001-certified and CAP-accredited laboratory certified under CLIA in Boulder, Colorado. For more information, visit www.natera.com.